Mendus AB: Report from the Extraordinary General Meeting of Mendus AB (publ) on 18 November 2022
Keep reading
Mendus AB: Mendus to host key opinion leader event on immunotherapy for maintenance treatment of Acute Myeloid Leukemia patients in remission
